A new randomized placebo-controlled study to establish the safety and efficacy of velmanase alfa (human recombinant alpha-mannosidase) enzyme replacement therapy for the treatment of alpha-mannosidosis

被引:0
|
作者
Harmatz, Paul [1 ]
Jayakar, Parul [2 ]
Pena, Loren D. M. [3 ,4 ]
Cattaneo, Federica [5 ]
Ceravolo, Ferdinando [5 ]
Paleari, Ylenia [5 ]
Sutton, Vernon R. [6 ]
Burton, Barbara K. [7 ,8 ]
Longo, Nicola [9 ]
机构
[1] UCSF Benioff Childrens Hosp, Oakland, CA USA
[2] Nicklaus Childrens Hosp, Miami, FL USA
[3] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[4] Univ Cincinnati, Cincinnati, OH USA
[5] Chiesi Farmaceut SpA, Parma, Italy
[6] Baylor Coll Med, Houston, TX 77030 USA
[7] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA
[8] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[9] Univ Utah, Salt Lake City, UT USA
关键词
D O I
10.1016/j.ymgme.2019.11.166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
157
引用
收藏
页码:S70 / S70
页数:1
相关论文
共 50 条
  • [1] Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis
    Harmatz, Paul
    Cattaneo, Federica
    Ardigo, Diego
    Geraci, Silvia
    Hennermann, Julia B.
    Guffon, Nathalie
    Lund, Allan
    Hendriksz, Christian J.
    Borgwardt, Line
    [J]. MOLECULAR GENETICS AND METABOLISM, 2018, 124 (02) : 152 - 160
  • [2] Long-term enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase) improves mobility in alpha-mannosidosis patients
    Lund, Allan M.
    Borgwardt, Line
    Amraoui, Yasmina
    Andersen, Oluf
    De Meirleir, Linda
    Dolhem, Philippe
    Gil Campos, Mercedes
    Guffon, Nathalie
    Heron, Benedicte
    Jameson, Elisabeth
    Jones, Simon A.
    Laroche, Cecile
    Lindberg, Christoffer
    Marquardt, Thorsten
    Mengel, Karl-Eugene
    Muschol, Nicole
    Tylki-Szymanska, Anna
    Van den Hout, Johanna M. P.
    Van der Ploeg, Ans
    Welling, Lindsey
    Wijburg, Frits
    Fogh, Jens
    Geraci, Silvia
    Ardigo, Diego
    Cattaneo, Federica
    [J]. MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S88 - S89
  • [3] Long-term enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase) slows disease progression in adult patients suffering from alpha-mannosidosis
    Borgwardt, Line
    Lund, Allan M.
    Amraoui, Yasmina
    Andersen, Oluf
    De Meirleird, Linda
    Dolhem, Philippe
    Campos, Mercedes Gil
    Guffon, Nathalie
    Heron, Benedicte
    Laroche, Cecile
    Lindberg, Christoffer
    Marquardt, Thorsten
    Mengel, Karl-Eugene
    Muschol, Nicole
    Tylki-Szymanska, Anna
    Van Den Hout, Johanna M. P.
    Van Der Ploeg, Ans
    Welling, Lindsey
    Wijburg, Frits
    Cole, Duncan
    Fogh, Jens
    Geraci, Silvia
    Ardigo, Diego
    Cattaneo, Federica
    [J]. MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S30 - S30
  • [4] Improvement in pulmonary function and serum immunoglobulin G in long-term enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase) in alpha-mannosidosis patients
    Borgwardt, Line
    Lund, Allan M.
    De Meirleir, Linda
    Amraoui, Yasmina
    Andersen, Oluf
    Dolhem, Philippe
    Campos, Mercedes Gil
    Guffon, Nathalie
    Heron, Benedicte
    Jameson, Elisabeth
    Jones, Simon A.
    Laroche, Cecile
    Lindberg, Christoffer
    Marquardt, Thorsten
    Mengel, Karl-Eugene
    Muschol, Nicole
    Van den Hout, Johanna M. P.
    Welling, Lindsey
    Wijburg, Frits
    Cole, Duncan
    Van der Ploeg, Ans
    Tylki-Szymanska, Anna
    Fogh, Jens
    Geraci, Silvia
    Ardigo, Diego
    Cattaneo, Federica
    [J]. MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S29 - S29
  • [5] Evaluation of 2 patients with alpha-mannosidosis and history of conductive hearing impairment participating in a placebo-controlled, phase 3 program receiving velmanase alfa (human recombinant alpha-mannosidase)
    Lund, Allan
    Borgwardt, Line Gutte
    Regal, Luc
    Cattaneo, Frederica
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S67 - S67
  • [6] Effect of velmanase alfa (human recombinant alpha-mannosidase) enzyme-replacement therapy on quality of life and disease burden of patients with alpha-mannosidosis: Results from caregiver feedback
    Lund, Allan
    Guffon, Nathalie
    Gil-Campos, Mercedes
    Cattaneo, Frederica
    Heron, Benedicte
    Tylki-Szymanska, Anna
    Borgwardt, Line
    Regal, Luc
    Cole, Duncan
    Hennermann, Julia
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S67 - S67
  • [7] The first study investigating safety and efficacy of velmanase alfa (human recombinant alpha mannosidase) in alpha-mannosidosis patients below six years of age
    Guffon, Nathalie
    Muschol, Nicole M.
    Konstantopoulou, Vassiliki
    Cattaneo, Federica
    Gelmetti, Elisabetta
    Tummolo, Albina
    Bruno, Irene
    Borgwardt, Line
    Hennermann, Julia B.
    Lund, Allan M.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S65 - S65
  • [8] Improvement in fine and gross motor proficiency after long-term enzyme replacement therapy with velmanase alfa (human recombinant alpha mannosidase) in alpha-mannosidosis patients
    Borgwardt, Line
    Lund, Allan M.
    Amraoui, Yasmine
    Andersen, Oluf
    De Meirleir, Linda
    Dolhem, Philippe
    Campos, Mercedes Gil
    Guffon, Nathalie
    Heron, Benedicte
    Jameson, Elisabeth
    Jones, Simon A.
    Laroche, Cecile
    Lindberg, Christoffer
    Marquardt, Thorsten
    Mengel, Karl-Eugene
    Muschol, Nicole
    Tylki-Szymanska, Anna
    Van den Hout, Johanna M. P.
    Van der Ploeg, Ans
    Welling, Lindsey
    Wijburg, Frits
    Fogh, Jens
    Geraci, Silvia
    Ardigo, Diego
    Cattaneo, Federica
    Phillips, Dawn
    [J]. MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S29 - S30
  • [9] Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosisKeywords
    Lund, Allan M.
    Borgwardt, Line
    Cattaneo, Federica
    Ardigo, Diego
    Geraci, Silvia
    Gil-Campos, Mercedes
    De Meirleir, Linda
    Laroche, Cecile
    Dolhem, Philippe
    Cole, Duncan
    Tylki-Szymanska, Anna
    Lopez-Rodriguez, Monica
    Guillen-Navarro, Encarna
    Dali, Christine I.
    Heron, Benedicte
    Fogh, Jens
    Muschol, Nicole
    Phillips, Dawn
    Van den Hout, J. M. Hannerieke
    Jones, Simon A.
    Amraoui, Yasmina
    Harmatz, Paul
    Guffon, Nathalie
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (06) : 1225 - 1233
  • [10] Global treatment response analysis of velmanase alfa long term enzyme replacement therapy for alpha-mannosidosis shows treatment benefit across ages
    Harmatz, Paul
    Cattaneo, Federica
    Ardigo, Diego
    Geraci, Silvia
    Muschol, Nicole
    Amraoui, Yasmina
    Gil-Campos, Mercedes
    Tylki-Szymanska, Anna
    Wijburg, Frits
    De Meirleir, Linda
    Van den Hout, Johanna M. P.
    Dali, Christine I.
    Jones, Simon A.
    Lund, Allan M.
    Borgwardt, Line
    Guffon, Nathalie
    [J]. MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S58 - S58